1132642-24-0

Basic information

• Product Name: 3-chloro-N-[[4-(trifluoromethyl)phenyl]carbamothioyl]benzamide
• Synonyms: 3-chloro-N-[[4-(trifluoromethyl)phenyl]carbamothioyl]benzamide
• CAS NO: 1132642-24-0
• Molecular Weight: 358.771
• Mol File: 1132642-24-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-chloro-N-[[4-(trifluoromethyl)phenyl]carbamothioyl]benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-N-[[4-(trifluoromethyl)phenyl]carbamothioyl]benzamide(1132642-24-0)
• EPA Substance Registry System: 3-chloro-N-[[4-(trifluoromethyl)phenyl]carbamothioyl]benzamide(1132642-24-0)

Safety Data

• Hazardous Substances Data: 1132642-24-0(Hazardous Substances Data)

Upstream product

• 455-14-1 4-trifluoromethylphenylamine 
• 28241-61-4 ammonia thiocyanic acid 
• 618-46-2 m-Chlorobenzoyl chloride 
• 535-80-8 3-chlorobenzoate 
• 66090-36-6 3-chlorobenzoyl isothiocyanate 

Relevant articles and documents

4-PHENYL-N-(PHENYL)THIAZOL-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS

4-phenyl-N-(phenyl)thiazol-2-amine and 4-(pyridin-3-yl)-N-( phenyl) thiazol-2-amine derivatives and the corresponding thiadiazole, thiophene, oxazole, oxadiazole, imidazole and triazole derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders.

F1F0-ATPASE INHIBITORS AND RELATED METHODS

The present invention relates to a family of guanidine-based F1F0-ATPase inhibitors, e.g., mitochondrial F1F0-ATPase inhibitors, methods for their discovery, and their use as therapeutic agents for treating certain disorders.